HMGN1 and neoplasm: Hepa1-6 tumor bearing mice after three rounds of treatment with HMGN1, R848 and anti-CTLA4 showed significantly increased infiltration of CD3+, CD4+, and CD8+ T cells (Figure 4A-4D) in tumor tissues.